Benutzer: Gast  Login
Titel:

Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Dokumenttyp:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Article
Autor(en):
Vaidya, Jayant S; Wenz, Frederik; Bulsara, Max; Tobias, Jeffrey S; Joseph, David J; Keshtgar, Mohammed; Flyger, Henrik L; Massarut, Samuele; Alvarado, Michael; Saunders, Christobel; Eiermann, Wolfgang; Metaxas, Marinos; Sperk, Elena; Sütterlin, Marc; Brown, Douglas; Esserman, Laura; Roncadin, Mario; Thompson, Alastair; Dewar, John A; Holtveg, Helle M R; Pigorsch, Steffi; Falzon, Mary; Harris, Eleanor; Matthews, April; Brew-Graves, Chris; Potyka, Ingrid; Corica, Tammy; Williams, Norman R; Baum, M...     »
Abstract:
The TARGIT-A trial compared risk-adapted radiotherapy using single-dose targeted intraoperative radiotherapy (TARGIT) versus fractionated external beam radiotherapy (EBRT) for breast cancer. We report 5-year results for local recurrence and the first analysis of overall survival.TARGIT-A was a randomised, non-inferiority trial. Women aged 45 years and older with invasive ductal carcinoma were enrolled and randomly assigned in a 1:1 ratio to receive TARGIT or whole-breast EBRT, with blocks strati...     »
Zeitschriftentitel:
Lancet
Jahr:
2014
Band / Volume:
383
Heft / Issue:
9917
Seitenangaben Beitrag:
603-13
Sprache:
eng
Volltext / DOI:
doi:10.1016/S0140-6736(13)61950-9
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/24224997
Print-ISSN:
0140-6736
TUM Einrichtung:
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie
 BibTeX